Atlas Trials

Single-dose Pharmacokinetics of BMS-626529, Administered as BMS-663068, in Subjects With Hepatic Impairment Compared to Healthy Subjects

Clinical trial NCT02467335 · COMPLETED

Trial details

NCT number
NCT02467335
Sponsor
ViiV Healthcare
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Infection, Human Immunodeficiency Virus
Start date
2015-01-29
Primary completion
2015-10-03
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.